Symbol="NBSE"
AssetType="Common Stock"
Name="NeuBase Therapeutics Inc"
Description="NeuBase Therapeutics, Inc., a preclinical biopharmaceutical company, focuses on developing therapies to treat rare genetic diseases and cancers caused by mutant genes. The company is headquartered in Pittsburgh, Pennsylvania."
CIK="1173281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="800 THIRD AVENUE, 11TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="September"
LatestQuarter="2023-06-30"
MarketCapitalization="2000900"
EBITDA="-23408468"
PERatio="None"
PEGRatio="None"
BookValue="5.99"
DividendPerShare="0"
DividendYield="0"
EPS="-21.95"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.43"
ReturnOnEquityTTM="-0.935"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-21.95"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="140"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.224"
EVToRevenue="-"
EVToEBITDA="0.524"
Beta="0.619"
num_52WeekHigh="15.6"
num_52WeekLow="0.605"
num_50DayMovingAverage="1.636"
num_200DayMovingAverage="3.547"
SharesOutstanding="2362400"
DividendDate="2019-02-04"
ExDividendDate="None"
symbol="NBSE"
open="0.74"
high="0.87"
low="0.70"
price="0.85"
volume="256384.00"
latest_trading_day="2023-08-22"
previous_close="0.78"
change="0.07"
change_percent="8.5619%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="391421"
Change_recent_avg="-0.03"
Delta_recent_avg="0.13"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.73"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1091"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_negative_thumbnail_id_2="503"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0102.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="612"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0096.jpeg"
image_positive_thumbnail_id_2="1011"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
